Gantenerumab companion diagnostic - Roche
Latest Information Update: 06 Aug 2012
At a glance
- Originator Roche
- Class Monoclonal antibody diagnostics
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Phase Unknown Alzheimer's disease
Most Recent Events
- 07 Jun 2012 Investigation in early stage Alzheimer's disease (diagnosis) in Switzerland (unspecified route)